Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Baxalta Inc.

Division of Shire PLC

Latest From Baxalta Inc.

Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline

Celgene will pursue "high-impact" indications using Vividion's proteomics technology, while Magenta will use Heidelberg's technology to try to optimize bone marrow transplants.

Deals M & A

Immunology Leads Shire's 2017 Sales Growth With Addition Of HAE Portfolio

Immunology portfolio yielded 14% sales growth in 2017, led by growing subcutaneous immunoglobulins and a still-rising HAE franchise. Dry eye drug Xiidra was another 2017 growth catalyst.
Sales & Earnings Business Strategies

Pharma Q4 Results Preview: Shire, Bayer, Merck KGaA

Potential upheavals in the hemophilia market bring uncertainty for Shire and Bayer, with executives likely to be quizzed on how they can retain market share during upcoming Q4 results calls. Scrip’s final earnings preview highlights the key challenges for large companies reporting at the tail-end of the earnings season.

Sales & Earnings Companies

Hemophilia Community Not 'Choosing A Side' In Hemlibra Litigation

Shire explains why it is seeking preliminary injunction against Genentech; National Hemophilia Foundation and Hemophilia Federation of America decline to take position on dispute.

BioPharmaceutical Policy
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Baxter BioScience
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Shire PLC
  • Senior Management
  • Ludwig N Hantson, PhD, Pres. & CEO
    Robert J Hombach, EVP, CF & COO
    John J Orloff, MD, EVP, Head, R&D & CSO
  • Contact Info
  • Baxalta Inc.
    Phone: (224) 940-2000
    One Baxter Pkwy.
    Deerfield, IL 60015